| Dr Stephanie Marin, PHARMD | |
|
3801 Howe Street, Oakland, CA 94612 | |
| (510) 752-6518 | |
| Not Available |
| Full Name | Dr Stephanie Marin |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 3801 Howe Street, Oakland, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407264914 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 70645 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Stephanie Marin, PHARMD 530 Vienna St., San Francisco, CA 94112-4396 Ph: () - | Dr Stephanie Marin, PHARMD 3801 Howe Street, Oakland, CA 94612 Ph: (510) 752-6518 |
News Archive
Obesity is the main cause of type 2 diabetes and related chronic illnesses that together will kill more people around the globe this year than the Covid-19 coronavirus.
Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced that top-line data from part one of a two-part Phase 1 study of SPI-1620 in combination with docetaxel was presented in an oral presentation at the 12th International Conference on Endothelin, held in Cambridge, United Kingdom, from September 11-14, 2011. Part one of the study has been completed, while part two is ongoing.
The Western Australia Corruption and Crime Commission is now inquiring into the case of a senior public servant who admitted to using his position in the Health Department to personally gain around a million dollars in money and gifts between 2004 and 2009.
Intellipharmaceutics International Inc. and its wholly owned subsidiary Intellipharmaceutics Corp. today announced that it and its licensee and development partner Par Pharmaceutical, Inc. ("Par") have received confirmation that the previously announced stays of the patent litigation concerning a generic version of Novartis' Attention Deficit Hyperactivity Disorder drug, Focalin XR®, (dexmethylphenidate hydrochloride), have expired without regulatory intervention, and that the parties have stipulated to a dismissal of the litigation.
Antiviral therapy may prevent the most common form of liver cancer developing among patients who have hepatitis C-related fibrosis or cirrhosis, report researchers.
› Verified 1 days ago
Dr. Gachiru L Kamau-devers, PHARM. D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3550 Fruitvale Ave, Oakland, CA 94602 Phone: 510-336-9305 Fax: 510-336-3925 | |
Jessica Chang, PHARM.D., APH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 280 W Macarthur Blvd, Oakland, CA 94611 Phone: 510-752-8859 | |
Trong-nghia Nguyen, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3320 Fruitvale Ave, Oakland, CA 94602 Phone: 510-530-3156 Fax: 510-530-1082 | |
Jocelyn Chan, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1800 Harrison St Fl 13, Oakland, CA 94612 Phone: 510-625-2139 | |
Norma Miyeko Marubayashi Holloway, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 280 W Macarthur Blvd, Oakland, CA 94611 Phone: 510-752-6468 | |
Mrs. Michele Ng, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 280 W Macarthur Blvd, Oakland, CA 94611 Phone: 510-752-6141 | |
Carol K Lam, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1800 Harrison St Ste 1301, Oakland, CA 94612 Phone: 626-941-4706 |